Advancing a Potential DNA Vaccine to Combat COVID-19
What’s it like to be part of a race that the whole world has their eyes on? Innovators around the globe have risen to the challenge of addressing COVID-19. Meet John Lewis, CEO of Entos Pharmaceuticals - a resident company of JLABS @ San Diego - who’s leading the company as they develop a potential DNA based vaccine aimed to prevent COVID-19. In this fireside chat, vaccine expert Jason Dehart, Sr. Principal Scientist at Janssen R&D, will guide a discussion with John around the current DNA vaccine landscape in infectious diseases, and how Entos’ proprietary platform for genetic medicine delivery may enable the formulation of a potential DNA vaccine for COVID-19.
The information on this webpage, including in the videos, is proprietary or licensed to Johnson & Johnson Innovation LLC, its parent company or any affiliate companies (“JJI”) and is for informational purposes only. This content is not intended to influence the use, sale, recommendation, or promotion of any products or services of Johnson & Johnson or its affiliates. The information presented in the videos is specific and applicable to region in which the original presentation took place. Many videos contain information from, or sessions given by, third parties. Please note that only those third parties that provide this information are responsible for it. By providing this information, JJI does not endorse these third parties or any of the information provided in these videos, and JJI makes no representations, warranties, or assurances, express or implied, as to the content or the information presented and is not responsible for any use of this information by you.